Literature DB >> 11436545

Psychological and screening profiles of first-degree relatives of prostate cancer patients.

S M Miller1, M A Diefenbach, L K Kruus, D Watkins-Bruner, G E Hanks, P F Engstrom.   

Abstract

The purpose of the present study was to systematically compare the psychological and screening profiles of first-degree relatives (FDRs) of prostate cancer patients versus non-FDRs. FDRs (n = 56) and non-FDRs (n = 100), recruited through prostate cancer index cases and newspaper advertisements, completed questionnaires via mail. FDRs reported feeling at greater risk for prostate cancer, estimated that they were at higher average lifetime risk for the disease, agreed more strongly that prostate cancer is inherited, and that less can be done to prevent the development of the disease. Increased age, but not FDR status, was associated with more frequent screening behavior. Taken together, the results indicate that FDRs are characterized by greater perceived vulnerability to prostate cancer and lower expectations about disease prevention. Yet, they are no more likely to be screened than non-FDRs. These findings underscore the importance of developing, and evaluating, evidence-based health communication protocols to promote screening adherence among at-risk patients.

Entities:  

Mesh:

Year:  2001        PMID: 11436545     DOI: 10.1023/a:1010766706914

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  36 in total

1.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.

Authors:  P Berthon; A Valeri; A Cohen-Akenine; E Drelon; T Paiss; G Wöhr; A Latil; P Millasseau; I Mellah; N Cohen; H Blanché; C Bellané-Chantelot; F Demenais; P Teillac; A Le Duc; R de Petriconi; R Hautmann; I Chumakov; L Bachner; N J Maitland; R Lidereau; W Vogel; G Fournier; P Mangin; O Cussenot
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.

Authors:  O J Austin; S Valente; L A Hasse; J R Kues
Journal:  Arch Fam Med       Date:  1997 Sep-Oct

3.  Changes in breast self-examination behavior achieved by 89,835 participants in the Canadian National Breast Screening Study.

Authors:  C J Baines; T To
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

Review 4.  Hereditary prostate cancer: epidemiologic and clinical features.

Authors:  B S Carter; G S Bova; T H Beaty; G D Steinberg; B Childs; W B Isaacs; P C Walsh
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

5.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.

Authors:  C Lerman; K Kash; M Stefanek
Journal:  J Natl Cancer Inst Monogr       Date:  1994

6.  Mendelian inheritance of familial prostate cancer.

Authors:  B S Carter; T H Beaty; G D Steinberg; B Childs; P C Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing.

Authors:  S J Jacobsen; S K Katusic; E J Bergstralh; J E Oesterling; D Ohrt; G G Klee; C G Chute; M M Lieber
Journal:  JAMA       Date:  1995-11-08       Impact factor: 56.272

8.  Performance of breast self-examination by women at high risk for breast cancer.

Authors:  S W Alagna; P J Morokoff; J M Bevett; D M Reddy
Journal:  Women Health       Date:  1987

9.  Psychological distress and surveillance behaviors of women with a family history of breast cancer.

Authors:  K M Kash; J C Holland; M S Halper; D G Miller
Journal:  J Natl Cancer Inst       Date:  1992-01-01       Impact factor: 13.506

10.  Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.

Authors:  L C Clark; B Dalkin; A Krongrad; G F Combs; B W Turnbull; E H Slate; R Witherington; J H Herlong; E Janosko; D Carpenter; C Borosso; S Falk; J Rounder
Journal:  Br J Urol       Date:  1998-05
View more
  12 in total

1.  [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].

Authors:  T Paiss; D Kahn; R Küfer; C Maier; W Vogel; J E Gschwend; R E Hautmann; K Herkommer
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

2.  Understanding preventive behaviors among mid-Western African-American men: a pilot qualitative study of prostate screening.

Authors:  Idethia Shevon Harvey; Reginald J Alston
Journal:  J Mens Health       Date:  2011-05-01       Impact factor: 0.537

3.  Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.

Authors:  Roberto L Muller; Eliney F Faria; Gustavo F Carvalhal; Rodolfo B Reis; Edmundo C Mauad; Andre L Carvalho; Stephen J Freedland
Journal:  World J Urol       Date:  2012-07-21       Impact factor: 4.226

4.  Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style.

Authors:  Pagona Roussi; Suzanne M Miller; Veda N Giri; Elias Obeid; Kuang-Yi Wen; Erin K Tagai; John Scarpato; Laura Gross; Gem Roy
Journal:  J Health Psychol       Date:  2016-10-10

5.  Perceived risk and worry about prostate cancer: a proposed conceptual model.

Authors:  Julie B Schnur; Terry A DiLorenzo; Guy H Montgomery; Joel Erblich; Gary Winkel; Simon J Hall; Dana H Bovbjerg
Journal:  Behav Med       Date:  2006       Impact factor: 3.104

6.  First-degree relatives of persons suffering from osteoporosis: beliefs, knowledge, and health-related behavior.

Authors:  Perla Werner; David Olchovsky; Hava Erlich-Gelaki; Iris Vered
Journal:  Osteoporos Int       Date:  2003-04-18       Impact factor: 4.507

7.  Racial differences in prostate cancer screening by family history.

Authors:  Bettina F Drake; Christopher S Lathan; Cassandra A Okechukwu; Gary G Bennett
Journal:  Ann Epidemiol       Date:  2008-05-16       Impact factor: 3.797

8.  Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.

Authors:  Lauren P Wallner; Aruna V Sarma; Michael M Lieber; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Monica E Gowan; Steven J Jacobsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

9.  Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.

Authors:  Yen-Ching Chen; John H Page; Rong Chen; Edward Giovannucci
Journal:  Prostate       Date:  2008-10-01       Impact factor: 4.104

10.  Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.

Authors:  Claire E Wakefield; Bettina Meiser; Judi Homewood; Michelle Peate; Judy Kirk; Beverley Warner; Elizabeth Lobb; Clara Gaff; Kathy Tucker
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.